Q&A: Should you trust trending peptide injections? Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide Mixing Medications and Dietary Supplements Can Endanger Your Health FDA